Reducing Inflammation May Lower Dementia Risk in RA
Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk.
Stay updated with breaking news from Achectin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk.
The highest prevalence of HS is among people in their 20s and 30s, so clinicians are likely to encounter female patients with HS who are either pregnant or actively thinking about getting pregnant.
Subquantifiable brodalumab levels were associated with a lack of response after 12 weeks, in the retrospective study.
More studies are needed to determine if the results are applicable to other populations and how air pollution might affect psoriasis disease activity, the investigators write.